We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

Local pharmaceutical manufacturer Adcock Ingram says its push into non-regulated products where it has better pricing power is paying off, but it is looking for growth across all its business divisions even as it grapples with pandemic-induced shifts in consumer spending.        

The group, in which Bidvest has a controlling stake, has been bulking up its presence in areas such as shoe-care products, a move that has helped the revenue contribution from products that are not price regulated rise from about a third to just under half over the past two years...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now

Would you like to comment on this article?
Register (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.

Commenting is subject to our house rules.